Labetalol Hydrochloride

Product NDC: 58657-607
11-digit product format: 586570607
Labeler code: 58657
Product ID: 58657-607_39af022e-4753-49a9-85d4-3b6887f4bb20
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Labetalol
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Method Pharmaceuticals, LLC
Application: ANDA075215
Marketing category: ANDA
Marketing start: 2017-11-15
Marketing end: 0000-00-00
Substance: LABETALOL
Active strength: 300 mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	58657-607		D	Discontinued by firm	2026-08-17
excluded package	package	58657-607	58657-607-01	D	Discontinued by firm	2026-08-17
excluded package	package	58657-607	58657-607-50	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 45 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58657-607-01	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58657-607-50	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58657-607-01	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58657-607-50	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58657-607-01	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58657-607-50	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58657-607-01	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58657-607-50	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58657-607-01	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58657-607-50	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58657-607-01	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58657-607-50	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58657-607-01	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	58657-607-50	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58657-607-01	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	58657-607-50	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58657-607-01	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	58657-607-50	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58657-607-01	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	58657-607-50	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58657-607-01	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	58657-607-50	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58657-607-01	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	58657-607-50	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58657-607-01	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	58657-607-50	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58657-607-01	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	58657-607-50	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	58657-607-01	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	58657-607-50	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075215-001	LABETALOL HYDROCHLORIDE	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29
A075215-002	LABETALOL HYDROCHLORIDE	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29
A075215-003	LABETALOL HYDROCHLORIDE	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075215-001	AB
A075215-002	AB
A075215-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-002	LABETALOL HYDROCHLORIDE	200MG	TABLET / ORAL	AB	1999-07-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-003	LABETALOL HYDROCHLORIDE	300MG	TABLET / ORAL	AB	1999-07-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075215-001	LABETALOL HYDROCHLORIDE	100MG	TABLET / ORAL	AB	1999-07-29	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A075215-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075215-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075215-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075215-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075215-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075215-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075215-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075215-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075215-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075215-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075215-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075215-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075215-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075215-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075215-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075215-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075215-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075215-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075215-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075215-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075215-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075215-001	AB	1	`1e350fbaab3a…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
baf61d8c-dcd3-e95d-db84-9bb0d0a2b77f	Product name	2	20220311
759f1c41-9262-4238-8cee-33988631aaf4	Product name	5	20220217
3b2edbb4-6acf-4674-b1d9-22addd3dad21	Product name	1	20210527

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
58657-607-01	2021-12-30	LABETALOL HYDROCHLORIDE TABLETS USP
58657-607-50	2021-12-30	LABETALOL HYDROCHLORIDE TABLETS USP
58657-607-01	2020-01-31	LABETALOL HYDROCHLORIDE TABLETS USP
58657-607-50	2020-01-31	LABETALOL HYDROCHLORIDE TABLETS USP

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
58657-607-01	EA - Each	58657-607	d7f36d2f-59ad-416b-a23d-eb0c1bce9a7b	1	2017-12-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 19 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	3909ac9e-6818-4c5d-ad0e-52865a574b45	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	35e7bce0-d9ff-4f8b-95c5-218da2a2d929	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	f7f7fade-98a6-4741-bfb9-f1eb54ad4565	2026-03-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	0db22a64-1863-4188-850b-273ea746e327	2026-02-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	d8b69cc9-bdee-4e24-a3d8-d1887de5a17d	2026-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	6f919513-500e-4a05-935e-b6fc1615368a	2026-01-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Innogenix, Inc.	82fc2d64-0572-4a9b-94fc-f6eb8d930c54	2025-12-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Method Pharmaceuticals, LLC	733d6e32-ac90-4796-bf25-9d5887c897a5	2025-12-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	0dcd514d-bda8-484b-8cf1-f5656aaab9ce	2025-10-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	20c26652-52da-4eef-8486-f91eb30e9ff7	2025-10-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	REMEDYREPACK INC.	e2e50571-d8c1-43e7-b90f-877ba1c35c9b	2025-09-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	A-S Medication Solutions	5faacbcc-f88f-42f7-8702-791ee82c4d18	2025-01-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	64cd636d-8b48-4f29-b41d-4a048335793e	2024-11-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL	Marlex Pharmaceuticals Inc	28c91727-e5a8-48b3-a4df-d7bec8feda40	2024-10-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	94abdd54-a8e2-4858-8183-6c5d04dbceb5	2024-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	1fce27dd-90a6-45cf-9bd7-13147d3cc0d7	2024-08-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	706a877b-c388-43e7-b083-518111b288b0	2024-08-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	5a39bb96-4a60-49e8-859c-16bda0fe18e4	2024-06-05	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215
Labetalol Hydrochloride	LABETALOL HYDROCHLORIDE	Bryant Ranch Prepack	143ae21e-c350-4c92-b318-7537f4e46596	2024-04-08	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075215 application number: ANDA075215

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R5H8897N95	LABETALOL	36894-69-6	LABETALOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
896758	labetalol HCl 100 MG Oral Tablet	PSN	b4c13317-88eb-48f2-aba2-50f01c8ff938	1
896762	labetalol HCl 200 MG Oral Tablet	PSN	b4c13317-88eb-48f2-aba2-50f01c8ff938	1
896766	labetalol HCl 300 MG Oral Tablet	PSN	b4c13317-88eb-48f2-aba2-50f01c8ff938	1
896758	labetalol hydrochloride 100 MG Oral Tablet	SCD	b4c13317-88eb-48f2-aba2-50f01c8ff938	1
896762	labetalol hydrochloride 200 MG Oral Tablet	SCD	b4c13317-88eb-48f2-aba2-50f01c8ff938	1
896766	labetalol hydrochloride 300 MG Oral Tablet	SCD	b4c13317-88eb-48f2-aba2-50f01c8ff938	1

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LABETALOL HYDROCHLORIDE TABLETS USP	Method Pharmaceuticals, LLC	2021-12-30	HUMAN PRESCRIPTION DRUG LABEL	3
Labetalol	Marlex Pharmaceuticals Inc	2018-04-06	HUMAN PRESCRIPTION DRUG LABEL	1